Hengrui Medicine has repurchased 12.06 million shares, accounting for 0.18% of its total share capital, with a total expenditure of 772 million yuan as of May 31, 2026. This buyback, initiated on August 20, 2025, is intended for an A-share employee stock ownership plan and is set to conclude by August 19, 2026, with a budget of 1 to 2 billion yuan. Separately, Zhengzhou Coal & Electricity announced unusual stock price fluctuations, with its daily closing price increase accumulating to over 20% in three trading days, and has confirmed normal operations and no undisclosed material matters. AI
RANK_REASON The cluster contains multiple unrelated news items from a digest-style feed, making it difficult to form a cohesive story.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →